Leucinostatin H

Leucinostatin H is a polypeptide antibiotic discovered in Paecilomyces marquandii, characterized by a tertiary amine-oxide terminal group. Leucinostatin H exhibits inhibitory activity against Gram-positive bacteria, such as Bacillus subtilis, B. cereus, and Staphylococcus aureus (MIC 10-100 μg/mL) . Leucinostatin H holds potential for research in anti-infective and plant disease control applications[1].

Product Specifications

CAS Number

[109539-58-4]

UNSPSC

12352005

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Field of Research

Infection

Smiles

O=C(N[C@H](C[N+](C)(C)[O-])C)CCNC(C(C)(C)NC(C(C)(C)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC(C(C)(C)NC([C@H]([C@H](O)C(C)C)NC([C@H](CC(C)C)NC([C@@H]1C[C@@H](CN1C(/C=C/[C@@H](C)CC)=O)C)=O)=O)=O)=O)=O)=O)=O)=O

Molecular Formula

C57H103N11O12

Molecular Weight

1134.49

References & Citations

[1]Radics L, et al. Leucinostatins H and K, two novel peptide antibiotics with tertiary amine-oxide terminal group from Paecilomyces marquandii isolation, structure and biological activity. J Antibiot (Tokyo) . 1987 May;40 (5) :714-6.